Technical Analysis for COLL - Collegium Pharmaceutical, Inc.

Grade Last Price % Change Price Change
grade F 15.76 -1.75% -0.28
COLL closed down 1.75 percent on Friday, January 18, 2019, on 52 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical COLL trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Resistance Bearish 0.00%
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Outside Day Range Expansion 0.00%
Jan 17 20 DMA Resistance Bearish -1.75%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.75%
Jan 17 Narrow Range Bar Range Contraction -1.75%
Jan 17 NR7 Range Contraction -1.75%
Jan 15 Calm After Storm Range Contraction 0.77%
Jan 15 Inside Day Range Contraction 0.77%
Jan 14 Calm After Storm Range Contraction 0.13%

Older signals for COLL ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication. The company is also developing COL-172, an abuse-deterrent, extended-release oxymorphone for the treatment of chronic pain; COL-195, an abuse-deterrent, extended-release hydrocodone for the treatment of chronic pain; COL-196, a morphine formulation for the treatment of pain; and COL-171, a proprietary preclinical DETERx extended-release, abuse-deterrent methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.
Is COLL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.9
52 Week Low 13.7
Average Volume 493,831
200-Day Moving Average 19.5335
50-Day Moving Average 17.1198
20-Day Moving Average 16.089
10-Day Moving Average 15.595
Average True Range 1.0375
ADX 21.42
+DI 16.0125
-DI 27.2846
Chandelier Exit (Long, 3 ATRs ) 15.7275
Chandelier Exit (Short, 3 ATRs ) 17.3625
Upper Bollinger Band 18.1549
Lower Bollinger Band 14.0231
Percent B (%b) 0.42
BandWidth 25.6809
MACD Line -0.4292
MACD Signal Line -0.4252
MACD Histogram -0.004
Fundamentals Value
Market Cap 465.97 Million
Num Shares 29.6 Million
EPS -3.59
Price-to-Earnings (P/E) Ratio -4.39
Price-to-Sales 40.60
Price-to-Book 3.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.86
Resistance 3 (R3) 16.87 16.53 16.67
Resistance 2 (R2) 16.53 16.25 16.52 16.61
Resistance 1 (R1) 16.14 16.08 15.97 16.13 16.55
Pivot Point 15.80 15.80 15.71 15.79 15.80
Support 1 (S1) 15.41 15.52 15.24 15.40 14.97
Support 2 (S2) 15.07 15.35 15.06 14.91
Support 3 (S3) 14.68 15.07 14.85
Support 4 (S4) 14.67